OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Cardiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	445
A Woman With Recurrent Torsade de Pointes	272
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	260
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	238
Primary Prevention Management of Elevated Lipoprotein(a)	230
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	191
Error in Table 1	190
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	179
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	169
JAMA Cardiology	165
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	159
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	155
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	150
Chest Pain in a Middle-Aged Man	144
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	142
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	131
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	131
Midlife Wealth Mobility and Long-term Cardiovascular Health	126
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	126
Genome-Wide Association Study of Accessory Atrioventricular Pathways	126
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	123
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	109
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	105
JAMA Cardiology	103
Accountable Care Organization Participation and Cardiovascular Care Quality	101

USPSTF Report on Aspirin for Primary Prevention	101
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	98
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	98
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	97
JAMA Cardiology	94
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	92
Assessing Performance of Machine Learning—Reply	91
Supraventricular Tachycardia Following Mitral Valve Surgery	90
JAMA Cardiology	88
What Is Your Secret to Health?	87
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	86
Hypertriglyceridemia in the MESA Study—Reply	84
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	83
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	82
Innovation in Event Adjudication—Human vs Machine	82
Peak Oxygen Uptake vs Ventilatory Efficiency	81
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	81
Contribution of Clinical Trial Event Data by Data Source	81
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	80
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	80
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	79
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	79
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	77
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	76
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	74
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	73
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	72
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	72
User Trust in Artificial Intelligence–Guided Lung Ultrasound	71
Change to Open Access Status	68
Corrected to Open Access Status	68
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	67
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	65
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	65
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	64
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	64
Error in Figure	63
Young Man With Coarctation of the Aorta	62
JAMA Cardiology	61
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	60
PCSK9 in Familial Hypercholesterolemia and Beyond	60
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	59
JAMA Cardiology	59
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	58
Exercise Capacity in Young Adults Born Small for Gestational Age	58
Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	56
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	55
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors	55
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	55
An Expanded Heart Failure Indication for Sacubitril/Valsartan	54

Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	54
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	53
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	53
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	52
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	51
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	51
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	50
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	50
A Woman With Syncope and Frequent Premature Ventricular Contractions	49
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	49
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	49
To Occlude or Not to Occlude the Left Atrial Appendage in Women	49
JAMA Cardiology	49
Passing the Stethoscope	48
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	48
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	47
Error in Figure 1	47
Error in Abstract and Results	47
Troponins and Pregnancy—Reply	47
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	47
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	46
Preserving and Promoting Clinical Trial Representativeness	46
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	46
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	46
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	45
When Is a Placebo Not a Placebo	45
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	45
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	45
Clonal Hematopoiesis—Fuel to Inflame the Heart	44
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	44
The 3.5-Inch View—On Perspective and the Medical Profession	44
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	43
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	43
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	43
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	42
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	42
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	42
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	42
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	41
Early Mortality in Type A Acute Aortic Dissection	40
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	40
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	40
A Patient in Their 30s With Dyspnea and a Spongy Heart	39
In Honor of the Pig	39
Incidental Complication From a Left Atrial Appendage Device	38
JAMA Cardiology	38
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	37
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	37
JAMA Cardiology	36
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	36
JAMA Cardiology	36
Errors in Key Points, Abstract, Results, and Figures	36
My Grandfather’s Blueprint	36
An Elderly Woman With Ventricular Tachycardia	36
Error in Abstract	35
Reflections of an Editorial Fellow—A Window Into Medical Publishing	35
Errors in Author Affiliations and Open Access Updated	35
Corrected to Open Access Status	35
Error in Table	35
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	34
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	34
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	34
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	34
Myocardial Infarction and Evolocumab	34
Preventing Declines in Cardiovascular Health From Childhood	34
Error in Results	33
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	33
The Last Mile in Prevention—Can Coronary CT Angiography Help?	33
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	33
The Limitations and Risks Associated With Semaglutide Treatment—Reply	33
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	33
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	33
Finerenone in Heart Failure—Reply	33
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	32
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	32
PREVENT Risk Age Equations and Population Distribution in US Adults	32
Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	31
Error in Corresponding Author Information	31
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk	31
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	31

Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	31
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	31
JAMA Cardiology	31
Comment on Aspirin Avoidance in Patients With LVADs	30
Moving Beyond Conventional Guesstimation to Guide PCI	30
Updated USPSTF Guidelines for Screening for Atrial Fibrillation	30
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	30
A Young Woman With Dyspnea During Cardiac Catheterization	30
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	30
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	30
Medicine, Writing, and the Limits of Language	30
JAMA Cardiology	29
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	29
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	29
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	28
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	28
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	28
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	28
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	28
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	27
JAMA Cardiology	27
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	27
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	27
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	27
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	27
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	27
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	27
JAMA Cardiology	26
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	26
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	26
A Teenager With Palpitations	26
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	25
The Fine Art and Science of Translating Trials Results Into Clinical Practice	24
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	24
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	24
Patient Enrollment for Cardiovascular Clinical Trials in the United States	24
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	23
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	23
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	23
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	23
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	23
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	23
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	23
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	23
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	22
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	22
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies	22
Authenticity—An Uphill Battle for a Black Woman in Cardiology	22
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	22
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	22
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	22
Variants at the Interleukin 1 Gene Locus and Pericarditis	21
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	21
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	21
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	21
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	21
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	21
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	21
JAMA Cardiology	21
Blood Pressure Control After SPRINT—Back to Reality	21
High-Risk Areas—The Trees in the Forest—Reply	21
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	21
Private Equity and Cardiovascular Health Care	21
Transient Monocular Blindness in a Man in His 30s	21
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction	21
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	20
Educational Attainment and Lifetime Risk of Cardiovascular Disease	20
Genetic Testing in Early-Onset Atrial Fibrillation	20
Long-term Survival After Out-of-Hospital Cardiac Arrest	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan	20
Hospitalization Rates Alone Do Not Define Health Systems—Reply	19
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	19
Error in Abstract and Methods	19
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	19
Salt Substitution and Recurrent Stroke and Death—Reply	19
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	19
Heart Failure—Together We Go Farther—Reply	18
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US	18
Omitted Affiliation	18
Error in the First Paragraph	18
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	18
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	18
JAMA Cardiology Peer Reviewers in 2021	18
Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region	18
Women’s Representation in Interventional Cardiology	18
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Errors in Abstract	18
Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart	17
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	17
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults	17